GMO Pepabo, Inc. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expects net sales of JPY 10,499 million, operating profit of JPY 732 million, profit attributable to owners of parent JPY 522 million and basic earnings per share of JPY 98.64.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,392 JPY | -0.57% | +2.43% | +19.08% |
13/02 | GMO Pepabo, Inc. Provides Dividend Guidance for the Year Ending December 31, 2024 | CI |
13/02 | GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.08% | 47.23M | |
+30.04% | 454B | |
+26.01% | 264B | |
+8.20% | 136B | |
+34.35% | 95.88B | |
+7.10% | 93.13B | |
+61.27% | 57.75B | |
+17.59% | 46.89B | |
+27.88% | 38.33B | |
+1.25% | 35.84B |
- Stock Market
- Equities
- 3633 Stock
- News GMO Pepabo, Inc.
- Gmo Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022